CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2025	Jun. 30, 2024	Jun. 30, 2025	Jun. 30, 2024
Revenue:
Total revenue	$ 101,005	$ 130,234	$ 187,698	$ 240,210
Operating expenses:
Cost of goods sold	27,630	29,198	51,353	57,894
Selling, general and administrative	73,810	76,540	146,319	148,862
Research and development	10,395	15,587	21,035	28,397
Write-down to fair value for asset held for sale	1,746		8,313
Impairment of property and construction		18,842		18,842
Write down of capitalized internal-use software costs		3,959		3,959
Total operating expenses	113,581	144,126	227,020	257,954
Loss from operations	(12,576)	(13,892)	(39,322)	(17,744)
Other income (expense), net:
Interest income (expense), net	669	(620)	1,630	(1,134)
Other income (expense), net	73	(28)	75	(5)
Total other income (expense), net	742	(648)	1,705	(1,139)
Net loss before income taxes	(11,834)	(14,540)	(37,617)	(18,883)
Income tax benefit (expense)	2,442	(2,503)	9,382	(260)
Net loss and comprehensive loss	(9,392)	(17,043)	(28,235)	(19,143)
Accretion of redeemable convertible preferred stock to redemption value	(129)	0	(250)	0
Cumulative dividend on redeemable convertible preferred stock	(2,681)		(5,308)
Net loss attributable to common stockholders, Basic, Total	(12,202)	(17,043)	(33,793)	(19,143)
Net income loss attributable to common stockholders - diluted	$ (12,202)	$ (17,043)	$ (33,793)	$ (19,143)
Net loss per share:
Basic	$ (0.1)	$ (0.13)	$ (0.27)	$ (0.14)
Diluted	$ (0.1)	$ (0.13)	$ (0.27)	$ (0.14)
Weighted-average common shares outstanding
Basic	126,853,536	132,573,153	126,576,130	132,217,463
Diluted	126,853,536	132,573,153	126,576,130	132,217,463
Net Product Revenue
Revenue:
Total revenue	$ 100,779	$ 130,234	$ 187,472	$ 240,210
Grant Income
Revenue:
Total revenue	$ 226		$ 226